James E Flynn insider trades

Open-market stock purchases and sales by James E Flynn, Director, 10% Owner at Nuvalent, Inc, from SEC Form 4 filings since Aug 5, 2014.

Track record: 9% of 74 scored buys are up 5% or more since purchase, averaging -34%.

Recent trades

DateStockTradeValue
Jun 16, 2026NUVL Nuvalent, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
Jun 11, 2026PBLS Parabilis Medicines, IncBought (not open market)—
May 19, 2026LRMR Larimar Therapeutics, IncBought (not open market)—
Feb 27, 2026LRMR Larimar Therapeutics, IncBought$5.4M
Feb 27, 2026LRMR Larimar Therapeutics, IncBought$4.2M
Feb 27, 2026LRMR Larimar Therapeutics, IncBought$10M
Feb 27, 2026LRMR Larimar Therapeutics, IncBought$5.4M
Nov 24, 2025NUVL Nuvalent, IncSold$35.4M

Companies traded

  • NUVL Nuvalent, Inc: 2 buys, 2 sales, last Jun 16, 2026
  • PBLS Parabilis Medicines, Inc: other filings, last Jun 11, 2026
  • LRMR Larimar Therapeutics, Inc: 13 buys, last May 19, 2026
  • SPRY ARS Pharmaceuticals, Inc: 8 sales, last Jun 27, 2025
  • PHGE BiomX Inc: other filings, last Apr 21, 2025
  • AFIB Acutus Medical, Inc: 4 buys, last Jan 27, 2025
  • BCAX Bicara Therapeutics Inc: 1 buy, last Sep 17, 2024
  • AHCO AdaptHealth Corp: 5 sales, last Mar 12, 2024
  • GUTS Fractyl Health, Inc: other filings, last Feb 6, 2024
  • CMAX CareMax, Inc: other filings, last Nov 17, 2023
  • ONCR Oncorus, Inc: 4 buys, 27 sales, last Dec 30, 2022
  • MIRM Mirum Pharmaceuticals, Inc: 1 buy, 10 sales, last Jun 6, 2022

Get free alerts when James E Flynn files a new trade →